Ldl-receptor genotype dependent response to cholesterol-lowering therapy in patients with heterozygous familial hypercholesterolemia

被引:0
|
作者
Kajinami, K [1 ]
Yagi, K [1 ]
Higashikata, T [1 ]
Inazu, A [1 ]
Koizumi, J [1 ]
Mabuchi, H [1 ]
机构
[1] KANAZAWA UNIV,SCH MED,DEPT INTERNAL MED 2,KANAZAWA,ISHIKAWA 920,JAPAN
关键词
D O I
10.1016/S0021-9150(97)88368-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:56 / 56
页数:1
相关论文
共 50 条
  • [1] Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia
    Miltiadous, George
    Saougos, Vasilios
    Cariolou, Marios
    Elisaf, Moses S.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (03): : 353 - 355
  • [2] Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry
    Roy, Gabrielle
    Couture, Patrick
    Genest, Jacques
    Ruel, Isabelle
    Baass, Alexis
    Bergeron, Jean
    Brisson, Diane
    Brunham, Liam R.
    Cermakova, Lubomira
    Gaudet, Daniel
    Khoury, Etienne
    Laflamme, Nathalie
    Kennedy, Brooke A.
    Hegele, Robert A.
    Drouin-Chartier, Jean-Philippe
    CANADIAN JOURNAL OF CARDIOLOGY, 2022, 38 (03) : 311 - 319
  • [3] PRAVASTATIN IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - LOW-DENSITY-LIPOPROTEIN (LDL) CHOLESTEROL-LOWERING EFFECT AND LDL RECEPTOR ACTIVITY ON SKIN FIBROBLASTS
    GADDI, A
    ARCA, M
    CIARROCCHI, A
    FAZIO, S
    DALO, G
    TIOZZO, R
    DESCOVICH, GC
    CALANDRA, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (10): : 1074 - 1078
  • [4] INFLUENCE OF SPECIFIC MUTATIONS AT THE LDL-RECEPTOR GENE LOCUS ON THE RESPONSE TO SIMVASTATIN THERAPY IN AFRIKANER PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    JEENAH, M
    SEPTEMBER, W
    VANROGGEN, FG
    DEVILLIERS, W
    SEFTEL, H
    MARAIS, D
    ATHEROSCLEROSIS, 1993, 98 (01) : 51 - 58
  • [5] NORMALIZATION OF LYMPHOCYTE LDL RECEPTOR FUNCTION IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS AFTER TREATMENT WITH CHOLESTEROL LOWERING DRUGS
    CUTHBERT, JA
    LIPSKY, PE
    CLINICAL RESEARCH, 1988, 36 (03): : A603 - A603
  • [6] CHOLESTEROL-LOWERING DRUG-THERAPY IN A PATIENT WITH RECEPTOR-NEGATIVE HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    FEHER, MD
    WEBB, JC
    PATEL, DD
    LANT, AF
    MAYNE, PD
    KNIGHT, BL
    SOUTAR, AK
    ATHEROSCLEROSIS, 1993, 103 (02) : 171 - 180
  • [7] NORMALIZATION OF LDL RECEPTOR FUNCTION BY LYMPHOCYTES OF PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AFTER TREATMENT WITH PLASMA-CHOLESTEROL LOWERING AGENTS
    CUTHBERT, JA
    EAST, CA
    LIPSKY, PE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1989, 298 (03): : 152 - 160
  • [8] Plasma lipoprotein (a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolaemia
    Miltiadous, G.
    Cariolou, M.
    Mitrogianni, Z. O. I.
    Doumas, M.
    Saougkos, V.
    Bairaktari, E.
    Elisaf, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 530 - 530
  • [9] DETECTION AND CHARACTERIZATION OF MUTATIONS IN THE LDL-RECEPTOR GENE IN A LARGE GROUP OF DUTCH PATIENTS, HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA (FH)
    DEFESCHE, JC
    LANSBERG, PJ
    RETIEF, AE
    REYMER, PW
    LAMPING, RJ
    KASTELEIN, JJP
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 916 - 916
  • [10] DUPLICATION OF EXONS 13, 14 AND 15 OF THE LDL-RECEPTOR GENE IN A PATIENT WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    LELLI, N
    GHISELLINI, M
    CALANDRA, S
    GADDI, A
    CIARROCCHI, A
    COVIELLO, DA
    BERTOLINI, S
    HUMAN GENETICS, 1991, 86 (04) : 359 - 362